China Money Network
Login
Join

Chinese Oncology-Focused Innovative Drugs Developer Haihe Biopharma Nets $146M

  • February 11, 2019 — 10:03 CST

This Data Is Locked!

This area is available only to Subscribers.

Haihe Biopharma Co., a Chinese pharmaceutical company specialized in innovative oncology drugs, has secured a US$146.6 million new round of investment led by China-focused private... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: